Company intelligence / Profile preview

PredictiMed

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

PredictiMed was a healthcare technology company that specialized in predictive modeling and health risk management solutions. The company's proprietary platform integrated clinical and claims data to identify individuals at high risk for chronic conditions, enabling healthcare providers and payers to implement targeted intervention strategies. By utilizing advanced analytics to predict future health risks and costs, PredictiMed provided actionable clinical decision support to improve population health outcomes. The company was acquired by Alere in 2008 to enhance its suite of health management and diagnostic services.

Therapeutic areas: CardiovascularEndocrinologyOther
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

AlereBlue Cross Blue Shield

Beyond the preview

Go deeper on PredictiMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PredictiMed.

Explore the full profile